Cumberland Pharmaceuticals Inc. - Common Stock (NQ:CPIX)

8.490 +0.010 (+0.12%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cumberland Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >

Cumberland Pharmaceuticals Q2 Earnings Call Highlights ↗

August 04, 2026

Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an...

Via MarketBeat

Topics Earnings

What's going on in today's pre-market session ↗

May 21, 2026

Via Chartmill

Cumberland (CPIX) Q4 2025 Earnings Call Transcript ↗

March 03, 2026

Cumberland (CPIX) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

CPIX Stock Earnings: Cumberland Reported Results for Q1 2024 ↗

May 07, 2024

Cumberland just reported results for the first quarter of 2024.

Via InvestorPlace

CPIX Stock Earnings: Cumberland Reported Results for Q4 2023 ↗

March 05, 2024

Cumberland just reported results for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 19, 2025

Via Benzinga

Cumberland (CPIX) Q2 Revenue Up 10% ↗

August 06, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 21, 2025

Via Benzinga

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session. ↗

February 19, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Via Chartmill

Here are the top movers in Wednesday's session. ↗

February 05, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

What's going on in today's session ↗

February 05, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

What's going on in today's after hours session ↗

February 04, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session. ↗

February 04, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease ↗

February 04, 2025

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

Via Benzinga

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 10, 2024

Via Benzinga

S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings ↗

December 10, 2024

Via Benzinga

Topics Stocks

Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings ↗

December 10, 2024

Via Benzinga

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? ↗

December 10, 2024

FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in hospitals worldwide.

Via Benzinga

Dow Falls 150 Points; Oracle Posts Downbeat Results ↗

December 10, 2024

Via Benzinga

Topics Stocks

Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

December 10, 2024

Via Benzinga

Earnings Scheduled For March 5, 2024 ↗

March 05, 2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

Via Benzinga

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 23, 2023

Gainers

Via Benzinga

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket ↗

May 23, 2023

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.